Shanghai Kehua Bio-Engineering Co Ltd Capital Reinvestment Ratio
Shanghai Kehua Bio-Engineering Co Ltd capital reinvestment ratio. Shanghai Kehua Bio-Engineering Co Ltd (002022) has a Capital Reinvestment Ratio of 1.11x as of September 2025, meaning it reinvests 1% of its operating cash flow (CN¥28.25 Million) in capital expenditures (CN¥31.24 Million). See Shanghai Kehua Bio-Engineering Co Ltd (002022) free cash flow to measure how efficiently the company converts operating cash flow to free cash.
Capital Reinvestment Ratio
Operating Cash Flow
Capital Expenditures
Data as of
Capital Reinvestment Ratio of Shanghai Kehua Bio-Engineering Co Ltd (2002–2025)
Capital reinvestment ratio of Shanghai Kehua Bio-Engineering Co Ltd from 2002 to 2025. This chart tracks Shanghai Kehua Bio-Engineering Co Ltd's Capital Reinvestment Ratio across 22 annual periods. See Shanghai Kehua Bio-Engineering Co Ltd financial flexibility index to measure the company's free cash flow as a share of total liabilities.
Shanghai Kehua Bio-Engineering Co Ltd Capital Reinvestment Ratio by Year (2002–2025)
Shanghai Kehua Bio-Engineering Co Ltd capital reinvestment ratio by year from 2002 to 2025. For the full cash flow conversion analysis, see cash flow conversion of Shanghai Kehua Bio-Engineering Co Ltd.
| Year | Reinvestment Ratio | Operating CF (CNY) | Capital Expenditures | YoY Change |
|---|---|---|---|---|
| 2025 | 6.21x | CN¥22.44 Million | CN¥139.29 Million | ▲ +3024.3% |
| 2022 | 0.20x | CN¥2.15 Billion | CN¥427.91 Million | ▼ -0.7% |
| 2021 | 0.20x | CN¥1.08 Billion | CN¥216.03 Million | ▲ +6.2% |
| 2020 | 0.19x | CN¥1.37 Billion | CN¥257.72 Million | ▼ -66.5% |
| 2019 | 0.56x | CN¥248.87 Million | CN¥140.21 Million | ▼ -42.4% |
| 2018 | 0.98x | CN¥126.79 Million | CN¥123.98 Million | ▲ +21.6% |
| 2017 | 0.80x | CN¥130.71 Million | CN¥105.12 Million | ▲ +119.1% |
| 2016 | 0.37x | CN¥281.25 Million | CN¥103.25 Million | ▼ -3.8% |
| 2015 | 0.38x | CN¥224.30 Million | CN¥85.62 Million | ▼ -5.3% |
| 2014 | 0.40x | CN¥249.64 Million | CN¥100.67 Million | ▲ +16.8% |
| 2013 | 0.35x | CN¥250.22 Million | CN¥86.37 Million | ▲ +1.1% |
| 2012 | 0.34x | CN¥213.74 Million | CN¥72.98 Million | ▲ +4.7% |
| 2011 | 0.33x | CN¥219.80 Million | CN¥71.65 Million | ▲ +107.9% |
| 2010 | 0.16x | CN¥241.83 Million | CN¥37.92 Million | ▼ -18.2% |
| 2009 | 0.19x | CN¥217.51 Million | CN¥41.71 Million | ▲ +49.1% |
| 2008 | 0.13x | CN¥137.66 Million | CN¥17.70 Million | ▼ -18.5% |
| 2007 | 0.16x | CN¥112.93 Million | CN¥17.81 Million | ▼ -45.1% |
| 2006 | 0.29x | CN¥87.21 Million | CN¥25.08 Million | ▲ +52.8% |
| 2005 | 0.19x | CN¥73.97 Million | CN¥13.92 Million | ▼ -79.5% |
| 2004 | 0.92x | CN¥48.74 Million | CN¥44.69 Million | ▲ +160.3% |
| 2003 | 0.35x | CN¥70.57 Million | CN¥24.86 Million | ▼ -29.0% |
| 2002 | 0.50x | CN¥41.48 Million | CN¥20.57 Million | — |